Humacyte, Inc. financial data

Symbol
HUMA, HUMAW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
2525 East North Carolina Highway 54, Durham, North Carolina
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Alpha Healthcare Acquisition Corp. (to 8/26/2021)
Latest financial report
Q1 2024 - May 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 719 % -20.9%
Debt-to-equity 341 % +291%
Return On Equity -307 % -1112%
Return On Assets -69.6 % -414%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 119 M shares +15.2%
Common Stock, Shares, Outstanding 119 M shares +15.2%
Entity Public Float 178 M USD +7.41%
Common Stock, Value, Issued 12 K USD +20%
Weighted Average Number of Shares Outstanding, Basic 108 M shares +4.83%
Weighted Average Number of Shares Outstanding, Diluted 108 M shares +4.83%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 80.5 M USD +25.4%
General and Administrative Expense 23.6 M USD +5.09%
Operating Income (Loss) -104 M USD -22%
Nonoperating Income (Expense) -1.59 M USD -103%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -106 M USD -263%
Earnings Per Share, Basic -1 USD/shares -245%
Earnings Per Share, Diluted -1 USD/shares -245%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 116 M USD -10.9%
Cash, Cash Equivalents, and Short-term Investments 80.4 M USD -47.1%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Assets, Current 118 M USD -11.9%
Property, Plant and Equipment, Net 25.7 M USD -13.3%
Operating Lease, Right-of-Use Asset 600 K USD -14.3%
Other Assets, Noncurrent 828 K USD
Assets 161 M USD -11.8%
Accounts Payable, Current 3.45 M USD +76.7%
Employee-related Liabilities, Current 3.38 M USD +18.7%
Accrued Liabilities, Current 7.92 M USD +23.5%
Liabilities, Current 14.1 M USD -40.3%
Deferred Income Tax Liabilities, Net 1.52 M USD -18.3%
Operating Lease, Liability, Noncurrent 600 K USD 0%
Other Liabilities, Noncurrent 830 K USD
Liabilities 135 M USD +33.9%
Retained Earnings (Accumulated Deficit) -569 M USD -22.8%
Stockholders' Equity Attributable to Parent 26.2 M USD -68.1%
Liabilities and Equity 161 M USD -11.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -27.3 M USD -46.7%
Net Cash Provided by (Used in) Financing Activities 62.8 M USD
Net Cash Provided by (Used in) Investing Activities -391 K USD +66.1%
Common Stock, Shares Authorized 250 M shares 0%
Common Stock, Shares, Issued 119 M shares +15.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 35.1 M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 116 M USD -10.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 152 M USD +15.7%
Deferred Tax Assets, Gross 153 M USD +15.2%
Operating Lease, Liability 632 K USD -9.71%
Depreciation 5.38 M USD -13.1%
Payments to Acquire Property, Plant, and Equipment 391 K USD -66.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -106 M USD -263%
Lessee, Operating Lease, Liability, to be Paid 889 K USD -10.6%
Property, Plant and Equipment, Gross 58.3 M USD +1.61%
Operating Lease, Liability, Current 55 K USD +10%
Lessee, Operating Lease, Liability, to be Paid, Year Two 105 K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 105 K USD 0%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 257 K USD -17.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 105 K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 80.8 M USD +19%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20 M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 105 K USD 0%
Additional Paid in Capital 595 M USD +9.16%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 1.52 M USD -18.3%
Share-based Payment Arrangement, Expense 6.47 M USD +0.42%
Interest Expense 6.72 M USD +3.85%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%